Earth Science Tech, Inc. (OTC: ETST) announced a series of strategic initiatives aimed at enhancing transparency, governance and alignment with long-term shareholder value as it advances toward becoming a fully institutional-ready public company. Building on approximately $3.3 million in net income for fiscal 2025 and anticipated $1.4 million in cost savings in fiscal 2026, the company outlined plans to optimize its portfolio through potential divestitures and brand consolidation, introduce advisory shareholder votes on executive compensation and Series B Preferred Stock retirement, rationalize its capital structure and reduce executive and board compensation, as management positions the company for disciplined growth and improved operating leverage.
The initiatives underscore Earth Science Tech's commitment to strengthening its corporate governance framework, a critical step for attracting institutional investors who often require robust oversight and transparency. By introducing advisory shareholder votes on executive compensation and Series B Preferred Stock retirement, the company is providing shareholders with a greater voice in key decisions, which could enhance trust and engagement. Additionally, rationalizing the capital structure through potential retirement of Series B Preferred Stock may simplify the equity structure and improve earnings per share metrics.
Management's decision to reduce executive and board compensation aligns with the company's focus on cost discipline. The anticipated $1.4 million in cost savings in fiscal 2026, combined with the fiscal 2025 net income of $3.3 million, positions Earth Science Tech to improve operating leverage. The potential divestitures and brand consolidation are part of a broader strategy to focus on core operations and optimize the portfolio for value creation.
Earth Science Tech, Inc. operates as a strategic holding company, focused on value creation through the acquisition, operational optimization, and management of its operating businesses. The Company’s current operations include compounding pharmaceuticals, telemedicine and real estate development through its wholly owned subsidiaries: RxCompoundStore.com, LLC, Peaks Curative, LLC, Avenvi, LLC, Mister Meds, LLC, and Earth Science Foundation, Inc., Las Villas Health Care, Inc., DOConsultations, LLC., and an 80% interest in MagneChef.
For more details, the full press release is available at https://ibn.fm/pNJIc. The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST.
